Effectiveness of Nurse-coordinated Follow-up Program in Primary Care for People at Risk for T2DM
Nurse-coordinated Follow-up Program in Primary Care: a Mixed-method Complex Intervention Feasibility and RCT Pilot Trial Among People at Risk for T2DM.
1 other identifier
interventional
81
1 country
1
Brief Summary
Previous Icelandic studies regarding prevalence of diabetes have mostly used data from the capital area. Information on the proportion of people at risk at developing T2DM or having undiagnosed T2DM among people living in rural Northern Iceland is unknown. Clinical guidelines recommend that patients with prediabetes (diabetes warning signs) should be referred to a counselling program. The study will evaluate effectiveness of nurse-coordinated Guided Self-Determination (GSD) follow up program toward health promotion, for people at risk of T2DM.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Nov 2021
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
December 1, 2020
CompletedFirst Posted
Study publicly available on registry
December 30, 2020
CompletedStudy Start
First participant enrolled
November 1, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 19, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
January 19, 2023
CompletedMay 24, 2023
May 1, 2023
1.2 years
December 1, 2020
May 23, 2023
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Cardiovascular Risk Factors changes up to one year after an intervention
Changes for each participant from Baseline to endpoint on CVR factors, changes of risk measured in percentages (%) compared to normal risk in the Icelandic population from beginning to end of intervention. Using the Icelandic cardiovascular risk factor calculator.
0- 6 months and 1 year
Measurements behind the Icelandic heart association risk calculator
Changes from baseline to endpoint: * Weight and height (will be combined to report BMI in kg/m\^2) * Systolic blood pressure: In mm hg * Cholesterol: in mmol/L * HDL-Cholesterol: in mmol/L * Triglycerides measurements: in mmol/L, * Regular physical activity: yes/no * Smoking: never, stopped, 1/2 pack or less a day, 1/2 to 1 pack a day, 1 pack or more * Do you have diabetes: yes/no, * Do gender parents, brothers or sisters of same parents, have cardiovascular diseases : Yes/No
0- 6 months and 1 year
Secondary Outcomes (6)
Changes in HbA1c level
0- 6 months and 1 year
FINDRISC risk score "Diabetes Risk Score questionnaire"
0- 6 months and 1 year
WHO-5 Quality of Life (QoL) questionnaire
0- 6 months and 1 year
EQ-5D-5L Questionnaire of self rated health.
0- 6 months and 1 year
Health Literacy (HL) questionnaire Icelandic version: HLS-EU-Q16IS.
0- 6 months and 1 year
- +1 more secondary outcomes
Other Outcomes (2)
Changes in fastening glucose from start point to endpoint in both groups
0- 6 months and 1 year
LDL cholesterol changes from start point to endpoint in both groups
0- 6 months and 1 year
Study Arms (2)
Intervention group
EXPERIMENTALThose receiving nurse-lead Guided Self Determination (GSD) for one to three times over six months starting four to six months after recruitment and first measurement.
Control group
NO INTERVENTIONThose not receiving nurse-lead Guided Self Determination (GSD) for one to three times over six months starting four to six months after recruitment and first measurement.
Interventions
Nurse lead intervention in primary care
Eligibility Criteria
You may qualify if:
- BMI ≥ 30 kg/m2,
- score ≥ 9 on FINDRISC,
- HbA1c level ≥ 42 mmol/mol.
- Non-blood-glucose-lowering medical treated T2DM.
You may not qualify if:
- People diagnosed with Diabetes at strart-point.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
University of Akureyri
Akureyri, 600, Iceland
Related Publications (15)
Andersen K, Aspelund T, Gudmundsson EF, Siggeirsdottir K, Thorolfsdottir RB, Sigurdsson G, Gudnason V. [Five decades of coronary artery disease in Iceland. Data from the Icelandic Heart Association]. Laeknabladid. 2017 Oktober;103(10):411-420. doi: 10.17992/lbl.2017.10.153. Icelandic.
PMID: 29044036BACKGROUNDKong AP, Luk AO, Chan JC. Detecting people at high risk of type 2 diabetes- How do we find them and who should be treated? Best Pract Res Clin Endocrinol Metab. 2016 Jun;30(3):345-55. doi: 10.1016/j.beem.2016.06.003. Epub 2016 Jun 11.
PMID: 27432070BACKGROUNDAmerican Diabetes Association. Standards of Medical Care in Diabetes-2016 Abridged for Primary Care Providers. Clin Diabetes. 2016 Jan;34(1):3-21. doi: 10.2337/diaclin.34.1.3. No abstract available.
PMID: 26807004BACKGROUNDZoffmann V, Kirkevold M. Realizing empowerment in difficult diabetes care: a guided self-determination intervention. Qual Health Res. 2012 Jan;22(1):103-18. doi: 10.1177/1049732311420735. Epub 2011 Aug 29.
PMID: 21876206BACKGROUNDIDF.org,( 2017). International Diabetes Federation,Webside. About Diabetes.accessed 28th of June 2018
BACKGROUNDBahler C, Huber CA, Brungger B, Reich O. Multimorbidity, health care utilization and costs in an elderly community-dwelling population: a claims data based observational study. BMC Health Serv Res. 2015 Jan 22;15:23. doi: 10.1186/s12913-015-0698-2.
PMID: 25609174BACKGROUNDThorsson B, Aspelund T, Harris TB, Launer LJ, Gudnason V. [Trends in body weight and diabetes in forty years in Iceland]. Laeknabladid. 2009 Apr;95(4):259-66. Icelandic.
PMID: 19420407BACKGROUNDZhang Y, Hu G, Zhang L, Mayo R, Chen L. A novel testing model for opportunistic screening of pre-diabetes and diabetes among U.S. adults. PLoS One. 2015 Mar 19;10(3):e0120382. doi: 10.1371/journal.pone.0120382. eCollection 2015.
PMID: 25790106BACKGROUNDWorld Health Organization. (2018). Diabetes fact sheet. Available from: World Health Organization, web site: http: //www.who.int/mediacentre/factsheeds/fs312/en (accessed 28. June 2018)
BACKGROUNDSaaristo T, Moilanen L, Jokelainen J, Korpi-Hyovalti E, Vanhala M, Saltevo J, Niskanen L, Peltonen M, Oksa H, Cederberg H, Tuomilehto J, Uusitupa M, Keinanen-Kiukaanniemi S. Cardiometabolic profile of people screened for high risk of type 2 diabetes in a national diabetes prevention programme (FIN-D2D). Prim Care Diabetes. 2010 Dec;4(4):231-9. doi: 10.1016/j.pcd.2010.05.005. Epub 2010 Jun 18.
PMID: 21134669BACKGROUNDSteinarsson AO, Rawshani A, Gudbjornsdottir S, Franzen S, Svensson AM, Sattar N. Short-term progression of cardiometabolic risk factors in relation to age at type 2 diabetes diagnosis: a longitudinal observational study of 100,606 individuals from the Swedish National Diabetes Register. Diabetologia. 2018 Mar;61(3):599-606. doi: 10.1007/s00125-017-4532-8. Epub 2018 Jan 9.
PMID: 29318343BACKGROUNDLaurant M, van der Biezen M, Wijers N, Watananirun K, Kontopantelis E, van Vught AJ. Nurses as substitutes for doctors in primary care. Cochrane Database Syst Rev. 2018 Jul 16;7(7):CD001271. doi: 10.1002/14651858.CD001271.pub3.
PMID: 30011347BACKGROUNDGustafsdottir SS, Sigurdardottir AK, Arnadottir SA, Heimisson GT, Martensson L. Translation and cross-cultural adaptation of the European Health Literacy Survey Questionnaire, HLS-EU-Q16: the Icelandic version. BMC Public Health. 2020 Jan 14;20(1):61. doi: 10.1186/s12889-020-8162-6.
PMID: 31937293BACKGROUNDSeidu S, Walker NS, Bodicoat DH, Davies MJ, Khunti K. A systematic review of interventions targeting primary care or community based professionals on cardio-metabolic risk factor control in people with diabetes. Diabetes Res Clin Pract. 2016 Mar;113:1-13. doi: 10.1016/j.diabres.2016.01.022. Epub 2016 Jan 21.
PMID: 26972954RESULTArnardottir E, Sigurdardottir AK, Skinner T, Graue M, Kolltveit BH. Prediabetes and cardiovascular risk factors: the effectiveness of a guided self-determination counselling approach in primary health care, a randomized controlled trial. BMC Public Health. 2024 Nov 1;24(1):3035. doi: 10.1186/s12889-024-20538-1.
PMID: 39487428DERIVED
Related Links
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- STUDY DIRECTOR
Arun K Sigurdardottir, PhD
University of Akureyri
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- PARTICIPANT
- Masking Details
- The participants is informed of two groups but not which group he is allocated in.
- Purpose
- PREVENTION
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
December 1, 2020
First Posted
December 30, 2020
Study Start
November 1, 2021
Primary Completion
January 19, 2023
Study Completion
January 19, 2023
Last Updated
May 24, 2023
Record last verified: 2023-05
Data Sharing
- IPD Sharing
- Will not share